4US Department of Health and Human Services.Medicare,Medicaid and CLIA program:Regulations implementing the Clinical Laboratory Improvement Amendment of 1988(CLIA).Final Rule with Comment Period[J].Fed Regist,1992,57(40):7002.
8Troughton JA,Woodside JV, Young IS, et al. Bilirubin and coro- nary heart disease risk in the Prospective Epidemiological Study of Myocardial Infarction(PRIME)[J]. Eur J Cardiovasc Prey Reha- bil,2007,14(1) :79-84.
9Sofronescu AG,Loebs T,Zhu Y. Effects of temperature and light on the stability of bilirubin in plasma samples [J]. Clin Chim Ae- ta,2012,413(3/4) :463-466.
10Hou S,Xu R,Clark JF, et al. Bilirubin oxidation end products di- rectly alter K+ channels important in the regulation of vascular tone[J]. J Cereb Blood Flow Metab,2011,31(1) ： 102-112.
